130 related articles for article (PubMed ID: 9221814)
1. Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors.
Rosell R; Pifarré A; Monzó M; Astudillo J; López-Cabrerizo MP; Calvo R; Moreno I; Sanchez-Céspedes M; Font A; Navas-Palacios JJ
Int J Cancer; 1997 Jun; 74(3):330-4. PubMed ID: 9221814
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer.
Pifarré A; Rosell R; Monzó M; De Anta JM; Moreno I; Sánchez JJ; Ariza A; Mate JL; Martińez E; Sánchez M
Br J Cancer; 1997; 75(2):184-9. PubMed ID: 9010024
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
4. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
5. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
6. Esophageal squamous cell carcinomas with DNA replication errors (RER+) are associated with p16/pRb loss and wild-type p53.
Mathew R; Arora S; Mathur M; Chattopadhyay TK; Ralhan R
J Cancer Res Clin Oncol; 2001 Oct; 127(10):603-12. PubMed ID: 11599796
[TBL] [Abstract][Full Text] [Related]
7. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
Froudarakis ME; Sourvinos G; Fournel P; Bouros D; Vergnon JM; Spandidos DA; Siafakas NM
Chest; 1998 Apr; 113(4):1091-4. PubMed ID: 9554652
[TBL] [Abstract][Full Text] [Related]
11. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
[TBL] [Abstract][Full Text] [Related]
12. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.
Field JK; Neville EM; Stewart MP; Swift A; Liloglou T; Risk JM; Ross H; Gosney JR; Donnelly RJ
Br J Cancer; 1996 Dec; 74(12):1968-74. PubMed ID: 8980398
[TBL] [Abstract][Full Text] [Related]
13. [Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung].
Sánchez Céspedes M; López Cabrerizo MP; Moreno I; Ariza A; Monzó M; Rosell R
Med Clin (Barc); 1997 May; 109(1):1-5. PubMed ID: 9303970
[TBL] [Abstract][Full Text] [Related]
14. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation.
Woenckhaus M; Stoehr R; Dietmaier W; Wild PJ; Zieglmeier U; Foerster J; Merk J; Blaszyk H; Pfeifer M; Hofstaedter F; Hartmann A
Int J Oncol; 2003 Nov; 23(5):1357-63. PubMed ID: 14532977
[TBL] [Abstract][Full Text] [Related]
16. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
[TBL] [Abstract][Full Text] [Related]
17. Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients.
Andjelkovic T; Bankovic J; Stojsic J; Milinkovic V; Podolski-Renic A; Ruzdijic S; Tanic N
Transl Res; 2011 Jan; 157(1):19-28. PubMed ID: 21146147
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
[TBL] [Abstract][Full Text] [Related]
19. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer.
Tseng RC; Chang JW; Hsien FJ; Chang YH; Hsiao CF; Chen JT; Chen CY; Jou YS; Wang YC
Int J Cancer; 2005 Nov; 117(2):241-7. PubMed ID: 15900585
[TBL] [Abstract][Full Text] [Related]
20. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women.
Nelson HH; Christiani DC; Mark EJ; Wiencke JK; Wain JC; Kelsey KT
J Natl Cancer Inst; 1999 Dec; 91(23):2032-8. PubMed ID: 10580029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
